Korean J Intern Med.  2024 Jul;39(4):603-611. 10.3904/kjim.2023.358.

Clinical course of asymptomatic duodenal subepithelial lesions

• Kang S
• Park K
• Kim DH
• Kim Y
• Na HK
• Lee JH
• Ahn JY
• Jung KW
• Choi KD
• Song HJ
• Lee GH
• Jung HY

• KMID: 2556910
• DOI: http://doi.org/10.3904/kjim.2023.358

Abstract

Background/Aims
There is limited knowledge regarding the management of duodenal subepithelial lesions (SELs) owing to a lack of understanding of their natural course. This study aimed to assess the natural course of asymptomatic duodenal SELs and provide management recommendations.
Methods
Patients diagnosed with duodenal SELs and followed up for a minimum of 6 months were retrospectively investigated.
Results
Among the 443,533 patients who underwent esophagogastroduodenoscopy between 2008 and 2020, duodenal SELs were identified in 0.39% (1,713 patients). Among them, 396 duodenal SELs were monitored for a median period of 72.5 months (interquartile range, 37.7–111.3 mo). Of them, 16 SELs (4.0%) showed substantial changes in size or morphology at a median follow-up of 35.1 months (interquartile range, 21.7–51.4 mo). Of these SELs with substantial changes, tissues of two SELs were acquired using endoscopic ultrasound-guided fine needle aspiration biopsy: one was a lipoma and the other was non-diagnostic. Three SELs were surgically or endoscopically removed; two were diagnosed as gastrointestinal stromal tumors, and one was a lipoma. An initial size of 20 mm or larger was associated with substantial changes during follow-up (p = 0.016).
Conclusions
While the majority of duodenal SELs may not exhibit substantial interval changes, regular follow-up with endoscopy may be necessary for cases with an initial size of 20 mm or larger, considering a possibility of malignancy.

Keyword

Duodenum; Endosonography; Gastrointestinal stromal tumors; Subepithelial lesions